Doctor: Al-Megrahi nearing death UPI Sun, 04 Apr 2010 05:40 AM PDT TRIPOLI, Libya, April 4 (UPI) -- Lockerbie bomber Abdelbaset Ali Mohmed al-Megrahi is "within four weeks" of dying of cancer in Libya, a British doctor says. | Event to benefit cancer relief Parker Chronicle Sun, 04 Apr 2010 04:53 AM PDT As a cancer survivor and a cyclist, one man is organizing a bike ride not just for other adult cyclists, but for the whole family. | Bar benefit helps man with cancer treatments Zanesville Times Recorder Sun, 04 Apr 2010 04:20 AM PDT ROSEVILLE --Family, friends and generous members of the community gathered Saturday to help raise funds to help an area man that many think of as a friend. | Lockerbie bomber expected to die "within four weeks" New Kerala Sun, 04 Apr 2010 03:38 AM PDT London, Apr. 4 : Lockerbie bomber Abdelbaset Ali Muhammad al-Megrahi, who was freed from a British prison on "compassion grounds" after being diagnosed for the terminal cancer, is expected to die "within four weeks." | Holly legend Duane Raffin dies of cancer Tri-County Times Sun, 04 Apr 2010 03:29 AM PDT Tom Flanigan was late for practice. And when he got to practice, Hollyâs ex-track and cross country coach Duane Raffin didnât let him forget it. âI came late to practice one day and, boy, did he get upset,â said Flanigan, a 1977 Holly graduate. | Partial Lung Removal Favorable Over Full Removal As Treatment For Lung Cancer According To Study Medical News Today Sun, 04 Apr 2010 03:24 AM PDT Research published in the April edition of the Journal of Thoracic Oncology sought to compare the outcomes of a sleeve lobectomy and a pneumonectomy procedure, in order to determine which is a more acceptable standard treatment for patients with non-small cell lung cancer. A pneumonectomy treatment involves removing one entire lung, whereas a sleeve lobectomy removes only a section of the lung ... | Tumor Cells Seek Temporary Shelter From Cancer Drugs Medical News Today Sun, 04 Apr 2010 03:22 AM PDT Results reported in the journal Cell, a Cell Press publication, reveal a new source for the drug resistance that crops up all too often and quickly in the tumors of cancer patients undergoing therapy. First the bad news: all cancer cells might have the capacity to enter a drug-tolerant state. But there's some potentially very good news too: in some cases there may be a way to reverse or block ... | | |
|
No comments:
Post a Comment